Richard Goldstein - Net Worth and Insider Trading
Richard Goldstein Net Worth
The estimated net worth of Richard Goldstein is at least $5,250 dollars as of 2024-11-13. Richard Goldstein is the 10% Security Holder, Director, Senior Officer of Canntab Therapeutics Ltd and owns about 1,050,000 shares of Canntab Therapeutics Ltd (XCNQ:PILL) stock worth over $5,250. Details can be seen in Richard Goldstein's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Richard Goldstein has not made any transactions after 2021-06-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Richard Goldstein
Richard Goldstein Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Richard Goldstein owns 1 companies in total, including Canntab Therapeutics Ltd (XCNQ:PILL) .
Click here to see the complete history of Richard Goldstein’s form 4 insider trades.
Insider Ownership Summary of Richard Goldstein
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| XCNQ:PILL | Canntab Therapeutics Ltd | 2021-06-04 | 10% Security Holder & Director & Senior Officer |
Richard Goldstein Latest Holdings Summary
Richard Goldstein currently owns a total of 1 stock. Richard Goldstein owns 1,050,000 shares of Canntab Therapeutics Ltd (XCNQ:PILL) as of June 4, 2021, with a value of $5,250.
Latest Holdings of Richard Goldstein
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| XCNQ:PILL | Canntab Therapeutics Ltd | 2021-06-04 | 1,050,000 | 0.01 | 5,250 |
Holding Weightings of Richard Goldstein
Richard Goldstein Form 4 Trading Tracker
According to the SEC Form 4 filings, Richard Goldstein has made a total of 9 transactions in Canntab Therapeutics Ltd (XCNQ:PILL) over the past 5 years, including 9 buys and 0 sells. The most-recent trade in Canntab Therapeutics Ltd is the acquisition of 24,000 shares on June 4, 2021, which cost Richard Goldstein around $23,040.
Insider Trading History of Richard Goldstein
- 1
Richard Goldstein Trading Performance
GuruFocus tracks the stock performance after each of Richard Goldstein's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Richard Goldstein is -20.05%. GuruFocus also compares Richard Goldstein's trading performance to market benchmark return within the same time period. The performance of stocks bought by Richard Goldstein within 3 months outperforms 0 times out of 9 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Richard Goldstein's insider trading performs compared to the benchmark.
Performance of Richard Goldstein
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -3.69 | | | | | |
| Relative Return to S&P 500(%) | -7.12 | | | | | |
Richard Goldstein Ownership Network
Ownership Network List of Richard Goldstein
Ownership Network Relation of Richard Goldstein
Richard Goldstein Owned Company Details
What does Canntab Therapeutics Ltd do?
Who are the key executives at Canntab Therapeutics Ltd?
Richard Goldstein is the 10% Security Holder & Director & Senior Officer of Canntab Therapeutics Ltd.
Canntab Therapeutics Ltd (XCNQ:PILL) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Canntab Therapeutics Ltd (XCNQ:PILL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Canntab Therapeutics Ltd (XCNQ:PILL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Canntab Therapeutics Ltd (XCNQ:PILL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Canntab Therapeutics Ltd Insider Transactions
Richard Goldstein Mailing Address
Above is the net worth, insider trading, and ownership report for Richard Goldstein. Currently GuruFocus does not have mailing address information for Richard Goldstein.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
